Autoimmune Disease
News on research and diagnostics in autoimmune disorders including rheumatoid arthritis, lupus, multiple sclerosis, and more.
Exagen, QMUL to Develop Molecular Signatures for Rheumatoid Arthritis Therapy Selection
The assays under development will segment patients according to gene expression in their synovial tissue biopsies to personalize therapy selection.
Exagen Q3 Revenues Rise 14 Percent
The firm's testing revenues grew to $11.9 million, up 25 percent compared to the previous year's quarter. Its flagship Avise CTD test generated $9.9 million in revenues.
The company has slightly extended its timeline for launching a Lyme disease test to focus on marketing its COVID assay for immunocompromised individuals.
Zeus Scientific Acquires Rights to Synthetic Peptides From Sheba Medical Center
Zeus intends to use the peptides to develop a new generation of immunoassays that will measure autoantibodies to diagnose rheumatoid arthritis.
Exagen Enters $27.2M Debt Refinancing Agreement
The term loan agreement with Innovatus Life Sciences Lending was originally inked in 2017, with an amendment in 2019.